Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/1998
05/14/1998WO1998019694A1 Therapeutic uses of bpi protein products in cystic fibrosis patients
05/14/1998WO1998019692A1 Nucleotide and amino acid sequences of a d2-2 gene associated with brain tumors and methods based thereon
05/14/1998WO1998019691A1 Dominant negative mutants of irs-1 and uses thereof
05/14/1998WO1998019689A1 Novel coding sequences
05/14/1998WO1998019686A1 Therapeutic methods for vascular injury
05/14/1998WO1998019674A2 A method for treating tension-type headache
05/14/1998WO1998019671A1 Methods and compositions for the treatment of bone resorption disorders, including osteoporosis
05/14/1998WO1998019670A2 Combination therapy of hepatitis c infections
05/14/1998WO1998019669A1 Chewing gum containing colloidal bismuth subcitrate
05/14/1998WO1998010085A3 Gene therapy for congestive heart failure
05/14/1998WO1998009602A3 Anti-atherosclerotic peptides and a transgenic mouse model of atherosclerosis
05/14/1998WO1998007859A3 Secreted proteins and polynucleotides encoding them
05/14/1998WO1998006864A3 Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat
05/14/1998WO1998006861A3 Delivery of tolerogenic antigens via edible plants or plant-derived products
05/14/1998WO1998006415A3 Anti-chlamydial methods and materials
05/14/1998WO1998005776A3 Secreted proteins and polynucleotides encoding them
05/14/1998WO1998005684A3 Mhc binding peptide oligomers and methods of use
05/14/1998WO1998005354A3 Treatment of stress-induced skin disease by corticotropin releasing hormone antagonists and skin mast cell degranulation inhibitors
05/14/1998WO1998004286A3 Assembly-deficient herpesvirus vaccine
05/14/1998WO1998003654A3 High-affinity interleukin-4 muteins
05/14/1998WO1998000172A3 Compositions and methods for altering the biodistribution of biological agents
05/14/1998WO1997048801A3 Polynucleotides encoding secreted proteins
05/14/1998WO1997044054A3 Type-2 chemokine binding proteins and methods of use therefor
05/14/1998CA2272991A1 Disruption of the mammalian rad51 protein and disruption of proteins that associate with mammalian rad51 for hindering cell proliferation
05/14/1998CA2271291A1 Protease-activatable pseudomonas exotoxin a-like proproteins
05/14/1998CA2271235A1 Glaucoma-associated protein and corresponding nucleic acid and their therapeutic and diagnostic uses
05/14/1998CA2270927A1 Novel pharmaceutical compositions
05/14/1998CA2270922A1 Identification of unique binding interactions between certain antibodies and the human b7.1 and b7.2 co-stimulatory antigens
05/14/1998CA2270909A1 Novel histamine h2 receptor
05/14/1998CA2270898A1 Isolated tumor necrosis factor receptor releasing enzyme, compositions comprising the enzyme and methods of the use thereof
05/14/1998CA2270869A1 Constrained helical peptides and methods of making same
05/14/1998CA2270867A1 Hepatocyte growth factor antagonists
05/14/1998CA2270619A1 Methods for promoting wound healing and treating transplant-associated vasculopathy
05/14/1998CA2270520A1 Chewing gum containing colloidal bismuth subcitrate
05/14/1998CA2270293A1 Fatty-acid amide hydrolase
05/14/1998CA2270291A1 Prostate-specific kallikrein
05/14/1998CA2270290A1 Therapeutic uses of bpi protein products in cystic fibrosis patients
05/14/1998CA2270288A1 Human monoclonal antibodies
05/14/1998CA2270284A1 Contryphan peptides
05/14/1998CA2270282A1 Novel coding sequences from herpes simplex virus type-2
05/14/1998CA2270173A1 Tumor-associated kazal inhibitor with pec-60 homology
05/14/1998CA2270171A1 Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines
05/14/1998CA2270160A1 Endothelium specific expression regulated by epcr control elements
05/14/1998CA2269757A1 Structure of secretory immunoglobulin a
05/14/1998CA2269665A1 Human regulator of g-protein signaling - (hrgs)
05/14/1998CA2269647A1 Human squalene epoxidase
05/14/1998CA2269646A1 Diabetes-mediating proteins and therapeutic uses thereof
05/14/1998CA2269641A1 Sprouty protein and coding sequence
05/14/1998CA2268354A1 Soluble proteins
05/14/1998CA2264610A1 Branched peptide linkers
05/14/1998CA2263199A1 Guanine exchange factor of rho gtpase and nucleic acid encoding it
05/14/1998CA2241911A1 Secreted proteins
05/14/1998CA2239463A1 Nucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereof
05/13/1998EP0841399A2 Mammalian fin-1 nucleic acid (a caspase) and protein sequences and uses therefor
05/13/1998EP0841398A2 Kojibiose Phosphorylase, its preparation and use
05/13/1998EP0841397A2 Trehalose phosphorylase, its preparation and uses
05/13/1998EP0841396A1 Human telomerase catalytic subunit
05/13/1998EP0841394A2 Staphylococcus aureus polynucleotides, polypeptides and their uses
05/13/1998EP0841393A1 HUMAN GALECTIN-4-LIKE PROTEIN AND cDNA ENCODING THE SAME
05/13/1998EP0841068A1 Leukemic cell growth inhibitor containing antisense oligonucleotide derivative against wilms' tumor gene (wt1)
05/13/1998EP0841067A1 Freeze-dried preparation containing monoclonal antibody
05/13/1998EP0841066A1 Stable freeze-dried composition containing tpo
05/13/1998EP0841065A2 Use of sericin as antioxidants and tyrosinase inhibitors
05/13/1998EP0841064A1 Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat lipopolysaccharide associated gram negative infections
05/13/1998EP0840801A2 Methods and compositions for identifying morphogen analogs
05/13/1998EP0840796A2 Mucosal delivery of polynucleotides
05/13/1998EP0840789A2 Transketolase-related protein
05/13/1998EP0840788A1 Novel serpin derived from human hypothalamus
05/13/1998EP0840787A2 A human edg-2 receptor homolog
05/13/1998EP0840785A1 A novel form of dipeptidylpeptidase iv (cd26) found in human serum, antibodies thereto, and uses therefor
05/13/1998EP0840750A1 Ha-2 antigenic peptide
05/13/1998EP0840749A1 The h-y antigen
05/13/1998EP0840748A1 Transforming growth factor beta crystals
05/13/1998EP0840743A1 Therapeutic oligonucleotides targeting the human mdr1 and mrp genes
05/13/1998EP0840729A1 Inhibitors of phospholipase a 2?
05/13/1998EP0840620A1 Il-8 antagonists for treatment of inflammatory disorders and asthma
05/13/1998EP0840619A1 Prevention and treatment of sepsis
05/13/1998EP0840618A1 Induction of immunological tolerance by the use of non-depleting anti-cd4 antibodies
05/13/1998EP0840617A1 Therapeutic and drug screening methods for the treatment and prevention of neuronal disease
05/13/1998EP0840616A1 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological disease
05/13/1998EP0840615A2 Chemokine binding protein and methods of use therefor
05/13/1998EP0840614A1 Calpain inhibitors for the treatment of neurodegenerative diseases
05/13/1998EP0840608A1 Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles
05/13/1998EP0840575A1 Angiogenic lipid formulations
05/13/1998EP0690721B1 Treatment of mycobacterial diseases by administration of bactericidal/permeability-increasing protein products
05/13/1998EP0668872B1 Calcium channel blocking polypeptides from theraphosidae aphonopelma
05/13/1998EP0625162B1 Methods of producing analgesia and enhancing opiate analgesia
05/13/1998EP0504239B1 Anistreplase for treating stroke
05/13/1998EP0375736B1 Nucleic acid fragments encoding mannose binding fragments of human mannose binding protein
05/13/1998CN1181783A Medical composition
05/13/1998CN1181760A Lipophilic peptide hormone derivatives
05/13/1998CN1181759A Process for the purification of glycoproteins like erythropoietin
05/13/1998CN1181758A Method for preparing streptogramines
05/13/1998CN1181755A THF-containing sulfonamide inhibitors of aspartyl protease
05/13/1998CN1181706A Arteriovenous and venous graft treatments: methods and compsns.
05/13/1998CN1181704A Use of glial neurotrophic factor (GDND) for treatment of hearing disorders
05/13/1998CN1181699A Aminotetralin derivative for the therapy of cardiovascular diseases
05/13/1998CN1181422A Gene transfer carrier structured by polypeptide in conjunction with growth factor receptor
05/13/1998CN1181420A Relative gene of hypertension
05/13/1998CN1038304C Method for prepn. of growth inhibiting compsn.
1 ... 2626 2627 2628 2629 2630 2631 2632 2633 2634 2635 2636 2637 2638 2639 2640 2641 2642 2643 2644 2645 2646 ... 3163